Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹781 Cr.
Stock P/E
17.1
P/B
1
Current Price
₹1397.9
Book Value
₹ 1390
Face Value
10
52W High
₹1481
52W Low
₹ 864
Dividend Yield
1.43%

Transpek Industry Overview

Business

Transpek Industry Ltd. is an Indian specialty chemical manufacturer. The company primarily produces a range of performance and specialty chemicals, including Sulphur-based chemicals (e.g., Thionyl Chloride, Sulphuric Acid derivatives, Chlorosulphonic Acid), Anhydrous Aluminum Chloride, and various other chemical intermediates. These products serve a diverse set of end-use industries such as pharmaceuticals, agrochemicals, polymers, dyes, textiles, personal care, and automotive. Transpek operates on a business-to-business (B2B) model, selling its manufactured chemicals to other industrial customers. The company focuses on developing customized and complex chemical solutions, leveraging its R&D capabilities and manufacturing expertise.

Revenue Mix

Transpek Industry Ltd. does not typically report its revenue segmented by distinct product lines (e.g., Sulphur chemicals vs. Aluminium Chloride) or end-user industries in its standard disclosures. However, its product portfolio broadly covers:

Sulphur-based chemicals: A significant part of their offerings, used across many industries.

Chlorination products: Including Anhydrous Aluminum Chloride, vital for organic synthesis.

Other intermediates: Specialized chemicals for various applications.

The company's revenue is generated from the sale of these chemical products to its industrial customer base.

Industry

Transpek operates within the fragmented yet growing Indian chemicals sector, specifically in specialty and performance chemicals. The industry is characterized by increasing demand from diverse end-use sectors and a global shift towards India as a manufacturing hub ("China+1" strategy). Transpek is a mid-sized player, known for its expertise in certain niche chemistries like sulphur chlorination and anhydrous aluminium chloride. Its positioning is built on strong R&D, long-standing customer relationships, and quality products, competing with both larger diversified chemical companies and smaller niche players in specific product categories.

MOAT

Process Expertise & R&D: Transpek has developed proprietary manufacturing processes for complex chemicals, offering efficiency and quality advantages. Its dedicated R&D focuses on new product development and process optimization.

Customer Approvals & Relationships: In specialty chemicals, getting product approvals and building trust with B2B customers is a lengthy process, creating high switching costs once a supplier is established. Transpek benefits from long-term relationships with key clients.

Backward Integration: For some of its key products, the company has backward integration, which helps in managing raw material quality, ensuring supply security, and potentially optimizing costs.

Niche Focus: Expertise in specific, often hazardous or complex, chemistries (e.g., handling Sulphur and Chlorine) creates barriers to entry for new players.

Growth Drivers

Growth in End-User Industries: Sustained demand from its key client sectors like pharmaceuticals, agrochemicals, polymers, and personal care will drive demand for its specialty chemical products.

New Product Development & Commercialization: The company's R&D focus on developing new derivatives and chemistries for emerging applications can expand its market reach and product portfolio.

Import Substitution & "Make in India": Government initiatives and a global trend towards reducing reliance on single-country supply chains could boost domestic manufacturing and demand for Transpek's products.

Capacity Expansion: Any future capacity additions for high-demand products would directly contribute to volume growth.

Risks

Raw Material Price Volatility: The company is susceptible to fluctuations in the prices of key raw materials like Sulphur, Aluminum, and various basic chemicals, which can impact profit margins.

Environmental & Regulatory Risks: The chemical industry is subject to stringent environmental norms. Any changes in regulations or non-compliance could lead to operational disruptions or penalties.

Intense Competition: The specialty chemicals market is competitive, with both domestic and international players vying for market share.

Economic Slowdown: A downturn in the global or Indian economy could reduce demand from end-user industries, impacting sales volumes and realizations.

Forex Fluctuations: Significant import of raw materials or export of finished goods exposes the company to foreign exchange rate volatility.

Management & Ownership

Transpek Industry Ltd. is promoted by the Ghia family, who have a long history in the Indian chemical industry. The management team has significant experience in the specialty chemicals sector, guiding the company's strategic direction, R&D efforts, and operational efficiency. The promoter group typically holds a substantial stake in the company, reflecting a long-term commitment. Ownership also includes institutional investors and public shareholders.

Outlook

Transpek Industry Ltd. is well-positioned to benefit from the secular growth trends in the Indian specialty chemicals sector, driven by increasing domestic consumption and global supply chain diversification. Its strong R&D capabilities and focus on niche, complex chemistries provide a competitive edge and potential for new product development. However, the company faces inherent challenges common to the chemical industry, including raw material price volatility, environmental compliance costs, and competition. Sustained growth will depend on its ability to effectively manage input costs, successfully commercialize new products, and navigate evolving regulatory landscapes while capitalizing on its established customer relationships and process expertise.

Transpek Industry Share Price

Live · BSE / NSE · Inception: 1965
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Transpek Industry Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 148 152 163 170 165 154 160 158 148 151
Other Income 5 11 5 5 8 12 5 4 4 4
Total Income 153 163 168 175 173 166 165 162 152 155
Total Expenditure 129 136 140 146 133 130 134 134 130 131
Operating Profit 24 27 28 29 40 36 32 28 22 24
Interest 3 3 3 3 3 2 2 2 2 2
Depreciation 11 12 13 12 13 12 12 12 12 11
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 9 12 12 14 25 21 17 14 9 12
Provision for Tax 3 2 2 3 5 5 4 4 2 3
Profit After Tax 6 9 10 11 19 16 13 11 7 9
Adjustments -0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 6 9 10 11 19 16 13 11 7 9
Adjusted Earnings Per Share 10.1 16.6 17.1 19.1 34.5 27.9 22.6 19.4 11.8 16

Transpek Industry Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 284 317 361 595 566 339 599 827 580 650 621 617
Other Income 4 7 10 18 17 17 29 18 25 29 25 17
Total Income 288 324 371 612 583 357 628 845 605 679 646 634
Total Expenditure 237 264 314 478 448 292 503 680 497 555 528 529
Operating Profit 51 60 57 134 135 64 125 165 107 123 118 106
Interest 11 9 12 19 16 10 11 19 14 12 8 8
Depreciation 8 9 10 14 26 29 30 33 38 50 49 47
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 32 42 35 101 94 26 84 113 56 62 61 52
Provision for Tax 10 12 9 36 21 2 19 29 17 13 16 13
Profit After Tax 21 30 26 66 73 23 65 83 39 49 46 40
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 21 30 26 66 73 23 65 83 39 49 46 40
Adjusted Earnings Per Share 36.2 53.7 47.3 117.7 130.6 41.7 117.1 149.5 69 87.3 81.7 69.8

Transpek Industry Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 91 206 247 311 338 380 484 587 673 745 767
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 26 25 85 69 45 44 35 28 20 21 14
Other Non-Current Liabilities 18 46 51 64 70 69 79 137 160 113 94
Total Current Liabilities 74 109 183 154 136 106 166 136 113 122 133
Total Liabilities 209 386 566 599 589 599 764 887 966 1001 1008
Fixed Assets 94 117 179 236 287 287 295 365 397 360 343
Other Non-Current Assets 20 150 211 189 143 158 225 287 355 340 329
Total Current Assets 95 119 177 173 159 154 244 234 214 301 337
Total Assets 209 386 566 599 589 599 764 887 966 1001 1008

Transpek Industry Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 1 2 0 1 0 0 15 2 5 8 57
Cash Flow from Operating Activities 44 47 7 128 111 35 47 111 98 135 78
Cash Flow from Investing Activities -16 -31 -103 -45 -33 -17 -70 -13 -32 -30 -38
Cash Flow from Financing Activities -27 -17 96 -83 -77 -3 9 -94 -64 -56 -40
Net Cash Inflow / Outflow 1 -1 0 -0 0 15 -14 4 3 48 1
Closing Cash & Cash Equivalent 2 0 1 0 0 15 2 5 8 57 58

Transpek Industry Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 36.24 53.67 47.27 117.69 130.59 41.74 117.09 149.45 69.03 87.25 81.72
CEPS(Rs) 50.38 69.12 65.04 143.01 176.96 92.77 170.31 208.57 136.35 176.75 168.8
DPS(Rs) 7.5 9 9 20 12.5 7.5 22.5 27.5 14 20 20
Book NAV/Share(Rs) 154.54 368.13 442.09 557.51 605.92 679.98 867.04 1050.26 1205.58 1334.36 1373.96
Core EBITDA Margin(%) 15.87 16.08 12.95 19.61 20.83 13.9 15.99 17.77 14.17 14.57 15.03
EBIT Margin(%) 14.36 15.72 12.9 20.23 19.32 10.59 15.81 15.94 12.03 11.29 11.15
Pre Tax Margin(%) 10.75 12.94 9.63 17.04 16.52 7.52 14.05 13.62 9.56 9.49 9.85
PAT Margin (%) 7.22 9.15 7.26 11.06 12.89 6.87 10.91 10.08 6.64 7.5 7.35
Cash Profit Margin (%) 10.04 11.78 9.99 13.43 17.46 15.26 15.87 14.06 13.11 15.19 15.18
ROA(%) 9.72 10.06 5.54 11.28 12.29 3.92 9.59 10.11 4.16 4.96 4.54
ROE(%) 25.71 20.23 11.67 23.55 22.45 6.49 15.14 15.59 6.12 6.87 6.03
ROCE(%) 27.58 22.98 12.62 26.57 24.27 7.81 17.43 20.66 10.11 9.79 8.7
Receivable days 79.21 63.12 80.65 57.37 59.07 89.16 53.36 47.88 65.98 54.6 74.28
Inventory Days 40.35 41.68 41.69 31.33 34.1 46.44 31.31 28.94 40.71 36.93 34.51
Payable days 97.06 66.62 83.88 68.95 78.11 99.15 53.67 46.13 63.56 60.09 83.57
PER(x) 10.93 11 26.09 12.77 9.41 32.67 16.66 9.84 25.78 14.29 10.72
Price/Book(x) 2.56 1.6 2.79 2.7 2.03 2.01 2.25 1.4 1.48 0.93 0.64
Dividend Yield(%) 1.89 1.52 0.73 1.33 1.02 0.55 1.15 1.87 0.79 1.6 2.28
EV/Net Sales(x) 1.03 1.32 2.46 1.65 1.4 2.46 1.95 1.06 1.74 0.97 0.67
EV/Core EBITDA(x) 5.79 6.92 15.66 7.31 5.86 12.94 9.38 5.3 9.38 5.12 3.54
Net Sales Growth(%) -2.04 11.59 14.08 64.64 -4.87 -40 76.52 38.02 -29.9 12.12 -4.41
EBIT Growth(%) 6.61 21.73 -8.91 156.33 -9.06 -67.13 163.67 39.3 -47.08 5.05 -5.65
PAT Growth(%) -3.14 40.88 -11.92 148.98 10.96 -68.04 180.55 27.64 -53.81 26.4 -6.34
EPS Growth(%) -3.14 48.1 -11.92 148.98 10.96 -68.04 180.55 27.64 -53.81 26.4 -6.34
Debt/Equity(x) 0.7 0.43 0.82 0.46 0.32 0.25 0.27 0.13 0.07 0.05 0.06
Current Ratio(x) 1.28 1.09 0.97 1.12 1.17 1.44 1.47 1.73 1.9 2.47 2.54
Quick Ratio(x) 0.77 0.75 0.72 0.76 0.8 1.1 1.07 1.25 1.33 1.92 2.16
Interest Cover(x) 3.98 5.66 3.94 6.34 6.9 3.45 8.99 6.87 4.87 6.25 8.59
Total Debt/Mcap(x) 0.27 0.27 0.29 0.17 0.16 0.12 0.12 0.1 0.04 0.05 0.09

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -4% -9% +13% +8%
Operating Profit CAGR -4% -11% +13% +9%
PAT CAGR -6% -18% +15% +8%
Share Price CAGR +3% -9% -9% +11%
ROE Average +6% +6% +10% +15%
ROCE Average +9% +10% +13% +17%

Transpek Industry Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 57.27 %
FII 0.02 %
DII (MF + Insurance) 0.98 %
Public (retail) 41.73 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 57.4757.4757.4757.4757.4757.4757.4757.4757.4757.27
FII 0.050.050.050.030.030.040.030.030.020.02
DII 1.791.791.791.791.791.761.571.571.530.98
Public 40.6940.6940.6940.7140.7140.7340.9340.9340.9841.73
Others 0000000000
Total 100100100100100100100100100100

Transpek Industry Peer Comparison

Chemicals Edit Columns

Transpek Industry Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Transpek Industry Pros & Cons

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 6% over the last 3 years.
  • Debtor days have increased from 60.09 to 83.57days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp